Sequencing Patterns and Treatment Effectiveness in ALK-positive aNSCLC Following First-Line Alectinib or BrigatinibI. Preeshagul, D. Abrahami, B. Li, D. Thomaidou, K. Duncan, S. Krulewicz, M. Rupp,J. BaumanJournal of Thoracic Oncology（2023）引用 0|浏览6暂无评分关键词ALK NSCLC,real world data,targeted therapiesAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
